Julie Schneider
Overview
Explore the profile of Julie Schneider including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1933
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Comandante-Lou N, Lama T, Chen K, Zhang J, Hu B, Liu S, et al.
bioRxiv
. 2025 Mar;
PMID: 40060644
Alzheimer's disease (AD) is marked by the coordinated emergence of disease-associated cell states across multiple cell types. Here, we first performed a meta-analysis of single-nucleus transcriptomic (snRNAseq) data from 869...
2.
Bay S, Rodina A, Haut F, Roychowdhury T, Argyrousi E, Staniszewski A, et al.
Res Sq
. 2025 Feb;
PMID: 39989971
Alzheimer's disease (AD) progresses as a continuum, from preclinical stages to late-stage cognitive decline, yet the molecular mechanisms driving this progression remain poorly understood. Here, we provide a systems-level map...
3.
Schilling K, Ramadass K, Sairanen V, Kim M, Rheault F, Newlin N, et al.
Hum Brain Mapp
. 2025 Feb;
46(3):e70143.
PMID: 39935269
Head motion during diffusion magnetic resonance imaging (MRI) scans can cause numerous artifacts and biases subsequent quantification. However, a thorough characterization of motion across multiple scans, cohorts, and consortiums has...
4.
Winfree R, Nolan E, Blennow K, Zetterberg H, Gifford K, Pechman K, et al.
Neurobiol Aging
. 2025 Jan;
147:141-149.
PMID: 39752902
We have identified FLT1 as a protein that changes during Alzheimer's disease (AD) whereby higher brain protein levels are associated with more amyloid, more tau, and faster longitudinal cognitive decline....
5.
Peterson A, Sathe A, Zaras D, Yang Y, Durant A, Deters K, et al.
Alzheimers Dement
. 2024 Dec;
21(1):e14343.
PMID: 39711105
Introduction: The effects of sex and apolipoprotein E (APOE)-Alzheimer's disease (AD) risk factors-on white matter microstructure are not well characterized. Methods: Diffusion magnetic resonance imaging data from nine well-established longitudinal...
6.
Le Borgne J, Gomez L, Heikkinen S, Amin N, Ahmad S, Choi S, et al.
Mol Psychiatry
. 2024 Dec;
PMID: 39633006
Due to methodological reasons, the X-chromosome has not been featured in the major genome-wide association studies on Alzheimer's Disease (AD). To address this and better characterize the genetic landscape of...
7.
Cherian L, Agarwal P, Agrawal S, James B, Yang D, Wagner M, et al.
medRxiv
. 2024 Nov;
PMID: 39606348
Background: This study investigates associations between diet patterns and the risk of intracranial atherosclerosis (ICAD) in individuals with preexisting hypertension (HTN) or myocardial infarction (MI). Method: 676 autopsied participants (mean...
8.
Balcomb K, Johnston C, Kavanagh T, Leitner D, Schneider J, Halliday G, et al.
Acta Neuropathol
. 2024 Nov;
148(1):72.
PMID: 39585417
SMOC1 has emerged as one of the most significant and consistent new biomarkers of early Alzheimer's disease (AD). Recent studies show that SMOC1 is one of the earliest changing proteins...
9.
Balcomb K, Johnston C, Kavanagh T, Leitner D, Schneider J, Halliday G, et al.
Res Sq
. 2024 Nov;
PMID: 39574902
SMOC1 has emerged as one of the most significant and consistent new biomarkers of early Alzheimer's disease (AD). Recent studies show that SMOC1 is one of the earliest changing proteins...
10.
Fan T, Decker W, Schneider J
Neurobiol Lang (Camb)
. 2024 Nov;
5(4):981-1007.
PMID: 39483699
Statistical learning (SL) is the ability to rapidly track statistical regularities and learn patterns in the environment. Recent studies show that SL is constrained by domain-specific features, rather than being...